Original language | English |
---|---|
Pages (from-to) | 325-332 |
Journal | Annals of Oncology |
Volume | 26 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2015 |
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
H. Bonnefoi, W. Jacot, M. Saghatchian, C. Moldovan, L. Venat-bouvet, K. Zaman, E. Matos, T. Petit, A. Bodmer, N. Quenel-tueux, C. Chakiba, P. Vuylsteke, G. Jerusalem, E. Brain, O. Tredan, C. G. M. Messina, L. Slaets, D. Cameron
Research output: Contribution to journal › Article › peer-review